Ziram is a dimethyldithiocarbamate
fungicide, which may influence
the male reproductive system as a potential endocrine disruptor. We
interrogated the disruption of ziram on rat progenitor Leydig cell
development. Prepubertal male Sprague–Dawley rats were orally
treated with 0, 2, 4, or 8 mg/kg ziram for 2 weeks. We investigated
the effects of ziram on serum testosterone levels, Leydig cell number,
and Leydig and Sertoli cell gene and protein expression, SIRT1/PGC-1α
levels, and phosphorylation of AKT1, ERK1/2, and AMPK in vivo. We also interrogated the effects of ziram on reactive oxidative
species (ROS) level, apoptosis rate, and mitochondrial membrane potential
of progenitor Leydig cells in vitro. Ziram decreased
serum testosterone and follicle-stimulating hormone levels, the down-regulated
Leydig cell-specific gene (Lhcgr, Scarb1, Star, Cyp17a1, and Hsd17b3), and their protein expression. However,
ziram stimulated anti-Müllerian hormone production. Ziram lowered
SIRT1/PGC-1α and phosphorylated protein levels of AKT1. Ziram
induced ROS and apoptosis and lowered the mitochondrial membrane potential
of progenitor Leydig cells in vitro. In conclusion,
ziram disrupts Leydig cell development during the prepubertal period
potentially through the SIRT1/PGC-1α and phosphorylated AKT1
signaling.